The 40-Gene Expression Profile Test Identifies Patients with National Comprehensive Cancer Network High-Risk Cutaneous Squamous Cell Carcinoma at High Risk of Poor Outcomes to Inform Management Decisions. J of Skin [Internet]. 2025 Jul. 23 [cited 2026 Feb. 1];9(4):2426-43. Available from: https://skin.dermsquared.com/skin/article/view/3561